If TIGAR expression is confirmed as a reliable prognostic marker in HCC, it could be integrated into predictive models, enabling clinicians to forecast patient outcomes accurately and customize therapeutic strategies. This evidence concerns the gene TIGAR and hepatocellular carcinoma.